TOOLS & RESOURCES

GLOBAL LEFT ATRIAL APPENDAGE
OCCLUSION SUMMIT

12TH GLOBAL LEFT ATRIAL
APPENDAGE OCCLUSION SUMMIT 2023

Left Atrial Appendage Occlusion therapy has become an established and increasingly popular alternative therapy to reduce the risk of AF-related stroke. Clinical research initiatives continue to show the therapeutic opportunities and benefits of this potentially lifesaving therapy. The objective of this meeting is to share ideas, thoughts and exchange experiences among experienced LAA occlusion devices and experts in the field of stroke prevention. It is designed to go beyond discussing the current available clinical data and aims to address new developments.

SESSION 1: WHAT IS NEW?

TRENDS AND RECENT DATA FOR LAA OCCLUSION THERAPIES – WHAT HAPPENED IN THE LAST 18 MONTHS
B. Schmidt
LAA OCCLUSION DEVICE DESIGN: SELECTION AND ANATOMIC CHALLENGES
R. Ibrahim
STROKE SEVERITY IN AF PATIENTS – LAA OCCLUSION VS NOACS
A. Aminian
TODAY'S CLINICAL REALITY; SELECTING THE OPTIMAL POST IMPLANT PHARMACOLOGICAL THERAPY
J. Kefer
LEAKS OR DRT - WHICH IS THE LESSER OF BOTH EVILS?
X. Freixa
SAFETY PROFILE OF MINIMAL ANTI- THROMBOTIC THERAPY IN CONCOMITANT F ABLATION & LAAO PROCEDURES
P. Kanagaratnam
PANEL DISCUSSION

SESSION 2: ANATOMY & IMAGING

UNDERSTANDING LAA ANATOMIES - A FIRST LOOK MIGHT BE DECEIVING
A. Cook
DO WE NEED CT TO REALLY UNDERSTAND THE ANATOMY?
C. Hammerstingl
HOW TO: ICE GUIDANCE FOR LAA OCCLUSION? WILL 4D MAKE A DIFFERENCE?
DJ. Lakkireddy
IMAGING: FUTURE PROMISES AND TODAY'S REALITIES
N. C. Wunderlich
PANEL DISCUSSION
INTERACTIVE DISCUSSION WITH PARTICIPANTS
LIVE CASE

SESSION 3: TIPS & TRICKS

NOT ALL LEAKS ARE THE SAME - PERI- DEVICE LEAK IS NOT INTRA-DEVICE LEAK - IMPACT ON PATIENT MANAGEMENT
A. Tzikas
MANAGEMENT OF COMPLICATIONS OF LAA OCCLUSION PROCEDURES (EMBOLIZATION, EFFUSIONS, GROIN MANAGEMENT)
J. Saw
HOW TO MAKE THE MOST CHALLENGING CASES A SUCCESSFUL IMPLANT
O. De Backer
THE GREAT HILDICK & SMITH DEBATE: CT OR NO-CT? THAT'S THE QUESTION.
D. Hildick-Smith
PANEL DISCUSSION
LIVE CASE

SESSION 4: PERSPECTIVES ON PATIENT INDICATIONS

LEAP OR LAG: LEFT ATRIAL APPENDAGE OCCLUSION AND GUIDELINES
J. Camm
POTENTIAL INDICATIONS FOR LAA OCCLUSION IN NEUROLOGICAL PATIENTS
K. Häusler
FUTURE PERSPECTIVES ON CLINICAL EVIDENCE GAPS AND FUTURE NEEDS
T. Lewalter
WRAP UP AND CLOSING REMARKS

Learn more about Left Atrial Appendage Occlusion.

Visit Product Page

MAT-2214725 v3.0 | Item approved for OUS use only.

Copyright © 2024 Abbott, 3200 Lakeside Dr, Santa Clara, 95054, U.S.A.
Caution: Product(s) are intended for use by or under the direction of a physician. Prior to use, reference to the Instructions for Use, inside the product carton (when available) or at www.eifu.abbott for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.
Illustrations are artist’s representations only and should not be considered as engineering drawings or photographs. Photos on file at Abbott.
Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

MAT-2000631 v18.0 | Item approved for OUS use only.

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.

YOU ARE ABOUT TO LEAVE
www.structural­heart.abbott

You are now leaving www.structuralheart.abbott. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

+